Article

jdsupra.com on 2023-09-29 20:17

Recent Biosimilar Commercialization Developments

Insulin Biosimilars: Meitheal Pharmaceuticals, Inc. has announced an exclusive licensing agreement with Tonghua Dongbao Pharmaceuticals Co., ...

Sima Lotfi

Related news

Recent Adalimumab Biosimilar Developments jdsupra.com
Recent Insulin Glargine Biosimilar Developments jdsupra.com
Recent Adalimumab Biosimilar Updates jdsupra.com
North America , Canada , Norway , Liechtenstein , Iceland
Recent Biosimilar Approvals jdsupra.com
Europe , Canada , United States
Update on Recent International Biosimilar Approvals jdsupra.com
China , Fuji-shi , Japan
New Developments in AbbVie’s BPCIA Suit Targeting Amgen’s Humira® Biosimilar jdsupra.com
CFIUS: Recent Developments and Trends jdsupra.com
Washington , Russia , France , Canada , Australia
Recent Developments in Green Bonds jdsupra.com
Mexico , China , India , Green Project
What Does Recent Biosimilar Approval By The FDA Mean?Forbes
Recent developments surrounding the South China Sea The Fresno Bee
Malaysia , Beijing , Philippines , United States , Vietnam